Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

J Mao1, D D Price, F S Caruso

  • 1Department of Anesthesiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.

Pain
|October 1, 1996
PubMed

Insights

Combining morphine sulfate (MS) with dextromethorphan (DM) orally prevented tolerance and dependence on MS in rats. This combination also enhanced MS pain relief, suggesting a novel approach for managing pain and opioid-related side effects.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Opioid analgesics like morphine sulfate (MS) are effective for pain but can lead to tolerance and dependence.
  • Dextromethorphan (DM), an NMDA receptor antagonist and antitussive, has shown potential in modulating opioid effects.

Purpose of the Study:

  • To investigate the efficacy of combined oral administration of MS and DM in preventing the development of tolerance and physical dependence on MS.
  • To assess whether DM can enhance the acute antinociceptive effects of MS.

Main Methods:

  • Rats were administered varying oral doses of MS alone or in combination with DM.
  • Tolerance to MS antinociception was assessed after repeated administration.
  • Physical dependence was evaluated through naloxone-precipitated withdrawal signs.
  • Acute antinociceptive effects of MS and DM combinations were measured.

Main Results:

  • Combined oral MS and DM administration prevented the development of tolerance to MS's antinociceptive effects across different MS doses.
  • This combination regimen also attenuated signs of naloxone-precipitated physical dependence on MS.
  • Various ratios of MS to DM (2:1, 1:1, 1:2) were effective in preventing tolerance and dependence.
  • DM was observed to enhance the acute antinociceptive effects of MS under certain conditions.

Conclusions:

  • Oral co-administration of dextromethorphan with morphine sulfate is a promising strategy for preventing opioid tolerance and dependence.
  • This combined approach may also enhance analgesia, offering a potential therapeutic advantage in pain management.
  • Further research into combining DM with opioid analgesics could lead to improved patient outcomes by mitigating major side effects.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...